Results 61 to 70 of about 172 (95)
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine. [PDF]
BMC Neurol, 2015 Blumenfeld AM +3 more
europepmc +1 more source